🇺🇸 FDA
Patent

US 10899710

Pyridines and their use in the treatment of cancer

granted A61KA61K45/06A61P

Quick answer

US patent 10899710 (Pyridines and their use in the treatment of cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K45/06, A61P, A61P35/00, A61P35/02